Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Moleculin Biotech Inc
MBRXCurrent price
0.94 USD
-0.02 USD (-2.11%)
Last closed
0.97 USD
Company
www.moleculin.com
ISIN
US60855D2009
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
12 882 867 USD
Yield for 12 month
-81.75 %
1Y
3Y
5Y
10Y
15Y
MBRX
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 3 clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma metastasized to the lungs. The company is also developing WP1066, an immune/transcription modulator designed to inhibit phosphorylated signal transducer and activator of transcription and other oncogenic transcription factors targeting brain tumors, and pancreatic and other cancers. In addition, it develops WP1220, an analog of WP1066 for the topical treatment of cutaneous lymphoma; and WP1122 to treat viruses, as well as cancer indications, including brain tumors, and pancreatic and other cancers. The company was incorporated in 2015 and is headquartered in Houston, Texas. Address: 5300 Memorial Drive, Houston, TX, United States, 77007
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+63 000 USD
Last Quarter
–
Current Year
–
Last Year
-127 000 USD
Current Quarter
+63 000 USD
Last Quarter
–
Key Figures MBRX
1 year
3 years
5 years
10 years
EBITDA
-25 782 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-62.45 %
PEG Ratio
–
Return On Equity TTM
-214.80 %
Wall Street Target Price
10.67 USD
Revenue TTM
–
Book Value
0.0030 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-6.32 USD
Diluted Eps TTM
-6.32 USD
Most Recent Quarter
I 2025
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MBRX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MBRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:15
Payout Ratio TTM
–
Last Split Date
22.03.2024
Stock Valuation MBRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.52
Price Book MRQ
2.15
Financials MBRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MBRX
For 52 weeks
0.40 USD
5.15 USD
50 Day MA
1.01 USD
Shares Short Prior Month
465 162
200 Day MA
1.87 USD
Short Ratio
2.23
Shares Short
725 045
Short Percent
5.17 %
BeatStart